$4.83 Billion is the total value of RTW INVESTMENTS, LP's 106 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RCKT | ROCKET PHARMACEUTICALS INC | $250,632,000 | -27.3% | 15,802,802 | 0.0% | 5.19% | +3.0% | |
| ESTA | ESTABLISHMENT LABS HLDGS INC | $156,287,000 | -0.3% | 2,319,138 | 0.0% | 3.24% | +41.3% | |
| MRTX | MIRATI THERAPEUTICS INC | $128,386,000 | -43.9% | 1,561,497 | 0.0% | 2.66% | -20.6% | |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | $99,728,000 | -13.6% | 1,373,284 | 0.0% | 2.06% | +22.4% | |
| CYTK | CYTOKINETICS INC | $94,277,000 | -19.2% | 2,561,182 | 0.0% | 1.95% | +14.4% | |
| RNA | AVIDITY BIOSCIENCES INC | $88,564,000 | -22.3% | 4,795,000 | 0.0% | 1.83% | +10.2% | |
| STOK | STOKE THERAPEUTICS INC | $76,711,000 | -12.3% | 3,644,248 | 0.0% | 1.59% | +24.4% | |
| AXSM | AXSOME THERAPEUTICS INC | $67,003,000 | +9.6% | 1,618,819 | 0.0% | 1.39% | +55.3% | |
| RGNX | REGENXBIO INC | $61,248,000 | +1.5% | 1,845,366 | 0.0% | 1.27% | +43.9% | |
| TXG | 10X GENOMICS INC | $55,872,000 | -48.9% | 734,481 | 0.0% | 1.16% | -27.7% | |
| DERMTECH INC | $45,782,000 | -7.1% | 3,118,666 | 0.0% | 0.95% | +31.7% | ||
| GHRS | GH RESEARCH PLCordinary shares | $39,670,000 | -21.6% | 2,168,957 | 0.0% | 0.82% | +11.1% | |
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $39,217,000 | -15.5% | 5,741,939 | 0.0% | 0.81% | +19.9% | |
| MGNX | MACROGENICS INC | $35,025,000 | -45.1% | 3,975,554 | 0.0% | 0.72% | -22.2% | |
| TARS | TARSUS PHARMACEUTICALS INC | $33,869,000 | -25.2% | 2,013,601 | 0.0% | 0.70% | +5.9% | |
| TENAYA THERAPEUTICS INC | $28,964,000 | -37.8% | 2,458,750 | 0.0% | 0.60% | -11.9% | ||
| MIST | MILESTONE PHARMACEUTICALS IN | $27,703,000 | -2.0% | 4,315,102 | 0.0% | 0.57% | +38.7% | |
| ATHA | ATHIRA PHARMA INC | $25,739,000 | +3.6% | 1,906,557 | 0.0% | 0.53% | +46.8% | |
| OYST | OYSTER PT PHARMA INC | $23,961,000 | -36.3% | 2,058,504 | 0.0% | 0.50% | -9.7% | |
| APYX | APYX MEDICAL CORPORATION | $22,191,000 | -49.1% | 3,398,279 | 0.0% | 0.46% | -27.8% | |
| VENTYX BIOSCIENCES INC | $21,058,000 | -31.7% | 1,551,778 | 0.0% | 0.44% | -3.1% | ||
| OLK | OLINK HLDG ABsponsored ads | $17,981,000 | -3.0% | 1,018,188 | 0.0% | 0.37% | +37.3% | |
| GLUE | MONTE ROSA THERAPEUTICS INC | $17,028,000 | -31.3% | 1,214,572 | 0.0% | 0.35% | -2.8% | |
| EPIX | ESSA PHARMA INC | $16,298,000 | -56.5% | 2,637,192 | 0.0% | 0.34% | -38.4% | |
| BWAY | BRAINSWAY LTDsponsored ads | $13,989,000 | +13.4% | 1,602,381 | 0.0% | 0.29% | +61.1% | |
| AADI BIOSCIENCES INC | $12,977,000 | -29.7% | 764,701 | 0.0% | 0.27% | -0.4% | ||
| PYXIS ONCOLOGY INC | $8,568,000 | -63.2% | 2,120,760 | 0.0% | 0.18% | -47.9% | ||
| URGN | UROGEN PHARMA LTD | $7,469,000 | -8.4% | 857,464 | 0.0% | 0.16% | +30.3% | |
| NYXOAH S A | $6,602,000 | -16.8% | 344,911 | 0.0% | 0.14% | +18.1% | ||
| LABP | LANDOS BIOPHARMA INC | $6,307,000 | -69.3% | 4,275,722 | 0.0% | 0.13% | -56.3% | |
| RACB | RESEARCH ALLIANCE CORP II | $6,217,000 | +0.4% | 637,000 | 0.0% | 0.13% | +43.3% | |
| BLSA | BCLS ACQUISITION CORP | $6,045,000 | +0.7% | 612,500 | 0.0% | 0.12% | +42.0% | |
| SMIHU | SUMMIT HEALTHCRE ACQUISTN COunit 06/03/2026 | $4,889,000 | -1.7% | 500,000 | 0.0% | 0.10% | +38.4% | |
| ARYD | ARYA SCIENCES ACQU CORP IVcl a | $4,900,000 | -1.2% | 500,000 | 0.0% | 0.10% | +40.3% | |
| ARYA SCIENCES ACQUISITN CORP | $4,855,000 | +0.1% | 500,000 | 0.0% | 0.10% | +40.8% | ||
| NAUT | NAUTILUS BIOTECHNOLOGY INC | $4,774,000 | -16.2% | 1,100,000 | 0.0% | 0.10% | +19.3% | |
| ROIVANT SCIENCES LTD | $3,965,000 | -51.0% | 802,717 | 0.0% | 0.08% | -30.5% | ||
| PNT | POINT BIOPHARMA GLOBAL INC | $3,905,000 | +42.3% | 490,000 | 0.0% | 0.08% | +102.5% | |
| FVAM | 5 01 ACQUISITION CORP | $3,861,000 | 0.0% | 392,000 | 0.0% | 0.08% | +42.9% | |
| ASLN | ASLAN PHARMACEUTICALS LTDads | $2,924,000 | -19.7% | 3,250,000 | 0.0% | 0.06% | +15.1% | |
| MSAC | MEDICUS SCIENCES ACQUISITION | $2,934,000 | +0.9% | 300,000 | 0.0% | 0.06% | +45.2% | |
| IMTX | IMMATICS N.V | $2,797,000 | -40.5% | 350,000 | 0.0% | 0.06% | -15.9% | |
| RXSIGHT INC | $1,857,000 | +10.0% | 150,000 | 0.0% | 0.04% | +52.0% | ||
| APEN | APOLLO ENDOSURGERY INC | $1,561,000 | -28.2% | 258,064 | 0.0% | 0.03% | 0.0% | |
| ISOPLEXIS CORP | $1,252,000 | -62.7% | 365,000 | 0.0% | 0.03% | -46.9% | ||
| MIRO | MIROMATRIX MED INC | $1,109,000 | -15.5% | 280,000 | 0.0% | 0.02% | +21.1% | |
| DNAY | CODEX DNA INC | $1,074,000 | -50.3% | 200,000 | 0.0% | 0.02% | -31.2% | |
| RCEL | AVITA MEDICAL INC | $905,000 | -29.2% | 106,667 | 0.0% | 0.02% | 0.0% | |
| MASS | 908 DEVICES INC | $760,000 | -26.6% | 40,000 | 0.0% | 0.02% | +6.7% | |
| MINERVA SURGICAL INC | $747,000 | -12.4% | 166,000 | 0.0% | 0.02% | +25.0% | ||
| OMIC | SINGULAR GENOMICS SYSTEMS IN | $631,000 | -45.4% | 100,000 | 0.0% | 0.01% | -23.5% | |
| ZY | ZYMERGEN INC | $202,000 | -56.8% | 70,000 | 0.0% | 0.00% | -42.9% | |
| RENOVACOR INC*w exp 99/99/999 | $109,000 | -45.5% | 350,000 | 0.0% | 0.00% | -33.3% | ||
| MSACW | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $14,000 | -41.7% | 33,331 | 0.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 36 | Q3 2023 | 19.7% |
| MASIMO CORP | 32 | Q3 2023 | 5.8% |
| LA JOLLA PHARMACEUTICAL CO | 31 | Q2 2022 | 9.7% |
| REGENXBIO INC | 30 | Q4 2022 | 10.8% |
| AGENUS INC | 29 | Q2 2022 | 9.0% |
| PTC THERAPEUTICS INC | 28 | Q3 2023 | 12.8% |
| DICERNA PHARMACEUTICALS INC | 28 | Q3 2021 | 10.8% |
| MIRATI THERAPEUTICS INC | 26 | Q3 2023 | 6.2% |
| ARGENX SE | 26 | Q3 2023 | 5.3% |
| VERICEL CORP | 24 | Q3 2023 | 3.9% |
View RTW INVESTMENTS, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | September 19, 2023 | 18,188,457 | - |
| ALLURION TECHNOLOGIES, INC. | August 11, 2023 | 3,457,707 | 7.4% |
| Orchestra BioMed Holdings, Inc. | May 05, 2023 | 5,620,645 | 15.7% |
| Renovacor, Inc.Sold out | April 05, 2023 | 0 | - |
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Aptevo Therapeutics Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ASLAN Pharmaceuticals LtdSold out | February 14, 2023 | 0 | 0.0% |
| Athira Pharma, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| BELLUS Health Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Clearside Biomedical, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View RTW INVESTMENTS, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-03-01 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View RTW INVESTMENTS, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.